Corporate Intelligence · Plain English · No Spin
S&P 500 · S&P 500 UNH · NYSE
Unitedhealth Group Inc
subscription mature-market
Net revenue
$91B
↑ 6% vs prior year
Gross margin
N/A
Net debt
N/A
Free cash flow
N/A
1974 2025
1974 Charter Med Founded
1977 UnitedHealthcare Created
1984 Goes Public
1988 Pharmacy Benefits Start
1994 Sells Pharmacy Unit
1995 MetraHealth Acquisition
Wikipedia history · XBRL financial data

UnitedHealth Group runs two giant businesses side by side. The first, UnitedHealthcare, sells health insurance — employers, individuals, and the government pay monthly premiums, and UnitedHealthcare pays the medical bills when members get sick. The second, Optum, is a collection of health services businesses: Optum Health manages doctors and clinics, Optum Insight runs health data and technology tools including the Change Healthcare payments network, and Optum Rx fills prescriptions. Together, these two sides generated $447.6 billion in total revenue in 2025. Nearly 80% of that revenue comes from premiums — recurring monthly payments that work like a subscription. The diagram below traces where the money goes.

How UnitedHealth Group Makes Money
flowchart TD A["Member Premiums\nnear 80% of $91.4B"] --> B["UnitedHealthcare\nBenefits $53.4B"] B -->|"contracts with"| C["Provider Network\nCompetitive Pricing"] D["Optum Services\n$38.0B"] --> C D --> B C -->|"controls medical costs"| E["Free Cash Flow\n$16.1B"] B --> E E --> F["Reinvest in Tech\nAI and Acquisitions"] F --> D

Five years of financial data tell a story of rapid growth followed by a sharp reversal. From 2021 to 2023, revenue climbed steadily — from $59.0 billion to $76.7 billion — and cash generation was strong. Free cash flow, the money left after running the business and maintaining its assets, hit $25.7 billion in 2023. That looked like a healthy, expanding machine.

Revenue Growth 2021–2025 ($B)
2021
$59.0B
2022
$65.0B
2023
$76.7B
2024
$86.3B
2025
$91.4B
Revenue grew every year, but the quality of that growth deteriorated sharply from 2024 onward.

Then something broke. Revenue kept rising in 2024 and 2025, reaching $91.4 billion in 2025. But free cash flow dropped hard — from $25.7 billion in 2023 down to $16.1 billion in 2025. Earnings from operations collapsed from $32.3 billion in 2024 to $19.0 billion in 2025, a fall of 41% in one year. Two things happened at once: medical costs surged well beyond what the company had predicted when setting prices, and a massive cyberattack hit the Change Healthcare business in early 2024, disrupting payments across the health system and triggering loans, reserves, and write-offs that bled into 2025.

What is the Medical Care Ratio?
The Medical Care Ratio, or MCR, measures how many cents of every premium dollar get spent on actual medical care. An MCR of 85% means 85 cents goes to doctors and hospitals, leaving 15 cents to cover running costs and profit. When medical costs rise faster than premiums, the MCR goes up and profits shrink. UnitedHealth's MCR rose from 83.2% in 2023 to 89.1% in 2025 — a significant deterioration.

The MCR shift is the clearest sign of pressure. In 2023, the company spent 83.2 cents of every premium dollar on medical care. By 2025, that figure had risen to 89.1 cents. That 5.9 percentage point swing wiped out billions in profit. The causes include Medicare Advantage funding cuts from the government that were not fully offset by pricing, sicker-than-expected patients in the value-based care business, and rising costs in Medicaid. At the same time, net debt — the company's borrowings minus cash — nearly doubled from $24.6 billion in 2021 to $54.0 billion in 2025, partly from acquisitions and partly from supporting providers during the cyberattack disruption.

$25.7B
Free Cash Flow 2023
$16.1B
Free Cash Flow 2025
Free cash flow dropped by $9.6 billion in two years, even as revenue grew by $14.7 billion over the same period.
2024
crisis
Change Healthcare Cyberattack
In February 2024, hackers attacked the Change Healthcare business, which processes payments between insurers and healthcare providers across the United States. The attack knocked out a critical piece of health system plumbing, forcing UnitedHealth to extend interest-free loans to providers who could not get paid. By the end of 2025, the company had increased reserves for loans it may not fully collect by $799 million. The full financial and reputational damage from this event continued to show up in results through 2025.

The risks documented in the company's own filings are specific and serious. The biggest is medical cost management. Nearly 80% of revenue comes from taking on the financial risk of medical costs — if actual costs exceed predictions, profits fall fast. The company itself states that relatively small differences between predicted and actual costs have resulted in significant changes in financial results. This is exactly what happened in 2024 and 2025. A second documented risk is cybersecurity: the 2024 Change Healthcare attack showed how a single breach in one part of the business can send shockwaves through the entire operation.

What is Medicare Advantage?
Medicare Advantage is a version of Medicare run by private insurance companies instead of the government directly. The government pays the insurer a fixed monthly amount per member, and the insurer covers the medical bills. If medical costs rise faster than the government's payments, the insurer absorbs the loss. UnitedHealthcare served 8.445 million Medicare Advantage members at the end of 2025 and expects that number to shrink in 2026 due to funding pressures.

Government program revenue is a third documented risk. A large portion of UnitedHealthcare's revenue flows from Medicare Advantage, Medicaid, and related government programs. The government sets the payment rates, and those rates have not kept up with rising medical costs. The company's own filings describe Medicare Advantage rate notices for multiple years as being well below the forward medical cost trend. A fourth risk sits on the balance sheet: goodwill and other intangible assets totaled $131 billion as of December 31, 2025, equal to 42% of total assets. These values were assigned when past acquisitions were completed. If those businesses underperform, the company may have to write down some of that value, reducing earnings and equity.

$131B
Goodwill and intangible assets on the balance sheet — 42% of total consolidated assets as of December 31, 2025

In the fourth quarter of 2025, management responded to the pressure with a significant restructuring. The company took $2.5 billion in restructuring charges — workforce reductions, real estate cuts, and a reserve for anticipated future losses in certain value-based care contracts. It also divested businesses and exited some markets. The stated goal is to sharpen focus on core businesses and restore profitability. But these actions mean the model as it existed through 2023 has already changed, and the new shape of the business is still being defined.

Optum Rx — the pharmacy benefit part of the business — was a rare bright spot. It grew operating earnings from $5.1 billion in 2023 to $7.2 billion in 2025, filling 1.659 billion adjusted prescriptions in 2025, up from 1.623 billion the year before.
89.1%
Medical Care Ratio in 2025 — up from 83.2% in 2023, meaning far less of each premium dollar is left to cover costs and generate profit
What is Value-Based Care?
In traditional healthcare, doctors and hospitals get paid for each service they perform — more visits, more money. Value-based care flips this: the insurer or care manager gets paid a fixed amount to keep a group of patients healthy. If they succeed in keeping costs low and outcomes good, they profit. If patients are sicker than expected or costs rise, the care manager absorbs the loss. UnitedHealth's Optum Health business took on large value-based care contracts that turned unprofitable in 2024 and 2025.
The Bet
UnitedHealth can reprice its insurance plans fast enough and accurately enough to get medical costs back below the level of premiums collected — and that the value-based care model, once restructured, will deliver the lower costs it promises rather than keep absorbing losses. If medical cost inflation stays elevated, if Medicare Advantage funding remains below trend, or if the value-based care business cannot be repriced and restructured into profitability, then the core mechanism that turns premium volume into cash flow stays broken — and the revenue growth visible in the five-year chart means very little.
Open question
The company collects premiums from roughly 49.8 million medical members and processes prescriptions and health data at enormous scale. That is a genuinely large and entrenched position in the U.S. health system. But entrenched does not mean immune: the MCR has moved sharply in the wrong direction, debt has doubled over five years, cash generation has fallen despite rising revenue, and the government — which sets rates for a huge portion of the business — has signaled further Medicare Advantage funding pressure in 2027. Can UnitedHealth reprice fast enough to close the gap between what it charges and what healthcare actually costs — and if it can, will it keep enough members to matter?
Compiled · 10-K · FY2025
Products
$53.4B
Services
$38.0B
Products is the largest revenue source at 58.4% of total.
XBRL · Revenue segments · FY2025
Gross margin is not applicable for banks — they earn through interest spread and fees, not product sales.
Operating Cash Flow (5-year)
2021
$22B
2022
$26B
2023
$29B
2024
$24B
2025
$20B
For banks, operating cash flow reflects loan origination and funding activity, not day-to-day profitability.
Cash Conversion
1.63×
XBRL · 10-K Financial Statements · FY2025
FY2025
$54B
↑ 5% year over year
FY2024
$52B
Banks hold large amounts of debt by design — they borrow cheaply (deposits, bonds) and lend at higher rates. The gap between those two rates is how they make money. Net debt figures here reflect that funding structure, not financial stress.
XBRL · Balance Sheet · 10-K · FY2025
Andrew
Chief Executive Officer
$26M
DEF 14A · Proxy Statement
2025-09-11
Baker Charles D.
Disc.
$0.01M
2025-06-10
Conway Patrick Hugh
CEO
Disc.
$0.18M
2025-05-16
REX JOHN F
President & CFO
Buy
$5.00M
2025-05-16
HEMSLEY STEPHEN J
CEO, UHG
Buy
$25.02M
2025-05-14
FLYNN TIMOTHY PATRICK
Buy
$0.49M
2025-05-15
Gil Kristen
Buy
$1.00M
2025-05-14
Noseworthy John H
Buy
$0.09M
2025-01-17
FLYNN TIMOTHY PATRICK
Buy
$0.51M
2024-11-11
McSweeney Erin
EVP & Chief People Officer
Disc.
$0.44M
2024-07-17
ROOS THOMAS E
Chief Accounting Officer
Disc.
$1.62M
6 purchases and 5 sales by insiders over the past two years.
Form 4 · SEC filings · Last 24 months
Vanguard Group
10.1%
BlackRock
8.1%
State Street
5.0%
Geode Capital Management
2.4%
T. Rowe Price
2.1%
JPMorgan Asset Mgmt
1.9%
Morgan Stanley
1.7%
Wellington Management
1.7%
Vanguard Group is the largest institutional holder with 10.1% of shares outstanding.
13F filings
Medical Cost Management
The company makes 80% of its revenue by taking financial risk on medical costs through insurance plans. If actual medical costs turn out higher than what the company predicted when setting prices, profits can drop significantly. Small differences between predicted and actual costs can cause major changes in financial results.
Cybersecurity & Data Breach
The company processes huge amounts of patient health information and personal data. In 2024, the Change Healthcare business it acquired was hit by a major cyberattack that exposed protected health information. Future breaches could disrupt operations, cause revenue loss, trigger lawsuits, and damage the company's reputation.
Government Program Revenue
The company gets substantial revenue from Medicare Advantage, Medicare Part D, Medicaid, and CHIP programs run by the government. The government can cut payments, change rules, or end contracts, which could materially reduce revenues and earnings.
Provider Relationships & Network Adequacy
The company depends on contracts with doctors, hospitals, and other providers to deliver care to patients. If providers refuse to contract, demand higher payments, or form large groups with strong bargaining power, the company's medical costs rise and profitability falls.
Goodwill Impairment
The company has $131 billion in intangible assets (goodwill) representing 42% of total assets, largely from past acquisitions. If acquired businesses underperform or the company divests assets, it could record large impairment charges that reduce earnings and equity significantly.
10-K Item 1A · Risk Factors
Cash vs earnings
AR growth
Inventory
Share dilution
Debt trend
One-time charges
Goodwill
Customer conc.
Nothing flagged.
10-K · XBRL · Computed signals